Similar articles

• Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.

  Paolocci N, Katori T, Champion HC, St John ME, Miranda KM, Fukuto JM, Wink DA, Kass DA. Paolocci N, et al. Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5537-42. doi: 10.1073/pnas.0937302100. Epub 2003 Apr 18. Proc Natl Acad Sci U S A. 2003. PMID: 12704230 Free PMC article.
• Nitroxyl effects on myocardium provide new insights into the significance of altered myofilament response to calcium in the regulation of contractility.

  Solaro RJ. Solaro RJ. J Physiol. 2007 May 1;580(Pt.3):697. doi: 10.1113/jphysiol.2007.131649. Epub 2007 Mar 8. J Physiol. 2007. PMID: 17347260 Free PMC article. No abstract available.
• Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure.

  Felker GM, Borentain M, Cleland JG, DeSouza MM, Kessler PD, O'Connor CM, Seiffert D, Teerlink JR, Voors AA, McMurray JJV. Felker GM, et al. Eur J Heart Fail. 2019 Aug;21(8):1022-1031. doi: 10.1002/ejhf.1504. Epub 2019 Jun 6. Eur J Heart Fail. 2019. PMID: 31168885 Review.
• Examining nitroxyl in biological systems.

  Fukuto JM, Jackson MI, Kaludercic N, Paolocci N. Fukuto JM, et al. Methods Enzymol. 2008;440:411-31. doi: 10.1016/S0076-6879(07)00826-9. Methods Enzymol. 2008. PMID: 18423233 Review.
• Nitroxyl (HNO): chemistry, biochemistry, and pharmacology.

  Fukuto JM, Switzer CH, Miranda KM, Wink DA. Fukuto JM, et al. Annu Rev Pharmacol Toxicol. 2005;45:335-55. doi: 10.1146/annurev.pharmtox.45.120403.095959. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822180 Review.